期刊文献+

胃癌、结肠癌中血管内皮生长因子的表达 被引量:2

Expressions of vascular endothelial growth factor in gastric and colonic cancer
下载PDF
导出
摘要 目的 研究血管内皮生长因子 (VEGF)在胃癌、结肠癌中的表达及意义。 方法 应用免疫组织化学技术 ,检测 35例胃癌、2 1例结肠癌中VEGF的表达。 结果  35例胃癌、2 1例结肠癌组织中 ,VEGF表达总阳性率 6 7.86 % (38/5 6 ) ,有淋巴结转移者VEGF表达阳性占 75 .6 1% (31/4 1) ,无淋巴结转移VEGF表达阳性占 4 6 .6 7% (7/15 ) (χ2 =4 .35 ,P <0 .0 5 )。癌组织浸润至浆膜层及浆膜外者VEGF表达阳性占 77.5 0 % (31/4 0 ) ,浸润至肌层及粘膜层者VEGF表达阳性占 4 3.75 % (7/16 ) (χ2 =6 .71,P <0 .0 1)。 结论 VEGF促进胃癌、结肠癌的生长、侵袭与转移 。 Objective To study the expressions of VEGF in gastric and colonic cncer. Methods The VEGF was detected by immunohistochemical method in 56 surgical samples of gastric or colonic cancer. Results Total positive rate of VEGF expression in gastric and colonic cancer was in 67.86%(38/56). In patients with lymphnode metastasis,the positive rate of VEGF expression was 75.61% (31/41), while in patients without lymphnode metastasis,the positive rate was 46.67%(7/15),χ 2=4.35, P<0.05. In patients with cancer tissue invaded into or beyond the serosa, the positive rate was 77.50%(31/40).In patients with cancer tissue invaded only into muscle or mucosa,the positive rate was 43.75%(7/16), χ 2=6.71,P<0.01. Conclusion VEGF can promote the growth, invasion and metastasis of gastric and colonic cancer, it play an important role in the tumor prognosis.
机构地区 宁波市第一医院
出处 《现代实用医学》 2002年第4期180-181,共2页 Modern Practical Medicine
关键词 胃癌 结肠癌 血管内皮生长因子 病理学 免疫组织化学 Gastric tumor/pathology Colonic tumor/pathology Lymphaokine+epithelial growth factor Immunohistochemistry/method
  • 相关文献

参考文献3

二级参考文献24

  • 1[1]Folkman J.Angiogenesis in cancer,vascular,rhenmatoid and other disease [J].Nature Med,1995,1(1) :27-30. 被引量:1
  • 2[2]Fontanini G,Vignati S,Lucchi M,et al.Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression [ J ].Br J Cancer,1997,75(9): 1295-301. 被引量:1
  • 3[3]Decaussin M,Sartelet H,Robert C,et al.Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival [J].J Pathol,1999,188 (2): 369-77. 被引量:1
  • 4[4]Volm M,Koomagi R,Mattern J.PD-ECGF,bFGF,and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis [J].Anticancer Res,1999,19(5) :651-655. 被引量:1
  • 5[5]Donala K ,Senger D,Livingston V ,et al.Vascular permeability factor ( VEGF,VPF) in tumor biology [ J ].Cancer Metastasis Rev,1993,12(3): 303-324. 被引量:1
  • 6Folkman J.Clinical applications of research on angiogenesis,1995. 被引量:1
  • 7Cao Y.Therapeutic potentials of angiostatin in the treatment of cancer,1999(07). 被引量:1
  • 8Boehm T;Folkman J;Browder T.Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance[J],1997(6658). 被引量:4
  • 9Hanahan D;Folkman J.Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis[J],1996(03). 被引量:4
  • 10Molema G;de Leij LF;Meijer DK.Tumor vascular endothelium: barrier target in tumor dirrected drug delivery and immunotherapy,1997(01). 被引量:1

共引文献16

同被引文献17

  • 1戴林,张学庸,陈宝军,王剑波,张惠中,樊代明.增殖细胞核抗原与胃癌淋巴结转移的关系[J].第四军医大学学报,1996,17(3):169-171. 被引量:6
  • 2黄选东,周雪瑞,沈阳,平洪.乳腺癌VEGF的表达与肿瘤生物学特性的关系[J].临床肿瘤学杂志,2005,10(6):624-626. 被引量:7
  • 3Shaheen RM, Davis DW, Liu W, et al. Antiangiogenic therapy targeting the tyrosine kinase, receptor for vascular endothelial growth factor receptor inhibist the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis[J]. Cancer Res, 1999, 59(21): 5412-5416. 被引量:1
  • 4Goldman CK, Kendall RL, Cabrera G, Soroeeanu L, et al.Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate [J]. Proc Natl Acad Sci USA, 1998, 95 ( 15 ) :8795-8800. 被引量:1
  • 5Keith W, Millokan MD, Julian W, et al. Do angiogenesis and growth factor expression predict prognosis of esophageal cancer[J]. The Aermica Surg, 2000, 4(66) : 401-403. 被引量:1
  • 6Chen QR, Kumar D, Stass SA, et al. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice[J]. Cancer Res, 1999, 59(14): 3308-3312. 被引量:1
  • 7Borgstrom P, Hillan KJ, Srirarnarao P, et al. Complete inhibition of angiogenesis and growth of microtumors by anti-VEGF neutralizing antibody: Novel concepts of angiostatic therapy from intravital videomicroscopy [J]. Cancer Res,1999, 56(17) : 4032-4039. 被引量:1
  • 8Wedge SR, Ogilvie DJ, Dukes M, et al. ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad spectrum antitumor efficacy [J]. Cancer Res,2000, 60(4): 970-975. 被引量:1
  • 9Watanabe O,Kinoshita J,Shimizu T,et al.Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer[J].Exp Clin Cancer Res,2005,24(1):75-82. 被引量:1
  • 10Jin Q,Hemminki K,Enquist K,et al.Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis[J].Clin Cancer Res,2005,11(10):3647-3653. 被引量:1

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部